Citation Impact
Citing Papers
Functionally specialized junctions between endothelial cells of lymphatic vessels
2007 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Cancer statistics, 2022
2022 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Phase I Trial of Single-Dose Temozolomide and Continuous Administration of O6-Benzylguanine in Children with Brain Tumors: a Pediatric Brain Tumor Consortium Report
2007
The Blood–Brain Barrier
2015 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Enzyme-Catalyzed Activation of Anticancer Prodrugs
2004
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
PRC2 is high maintenance
2019
Contribution of platelets to tumour metastasis
2011 Standout
Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma
2011
Clinical lessons learned from the first leg of the CAR T cell journey
2019
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Targeting TRK family proteins in cancer
2017
Soft-Tissue Sarcomas in Adults
2005 Standout
Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography–tandem mass spectrometry method for the analysis of fluconazole in human plasma
2003
TH1 predominance is associated with improved survival in pediatric medulloblastoma patients
2011
Cancer genes and the pathways they control
2004 Standout
Hydrophilic interaction chromatography
2006 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Targets for pharmacological intervention of endothelial hyperpermeability and barrier function
2002
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Genomic Insights into Diffuse Intrinsic Pontine Glioma
2017
Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway
2010
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
2009
A comprehensive outlook on intracerebral therapy of malignant gliomas
2010
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
2019
Malignant Gliomas in Adults
2008 Standout
Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer
2003
Analysis of anticancer drugs: A review
2011 Standout
Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery
2008
Overview of the clinical efficacy of investigational anticancer drugs
2003
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Targeting DNA repair mechanisms in cancer
2012
1H MR spectroscopy of brain tumours and masses
2003
Two-stage enzyme mediated drug release from LMWG hydrogels
2005 StandoutNobel
Primary brain tumours in adults
2012 Standout
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
2013
Histopathological Image Analysis: A Review
2009 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Emerging applications of metabolomics in drug discovery and precision medicine
2016
De novo design of tyrosine and serine kinase-driven protein switches
2021 StandoutNobel
Mechanisms of resistance to CAR T cell therapy
2019
Bioluminescent Probes of Sulfatase Activity
2010 StandoutNobel
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
The Protective Effect of Cyclosporin A upon N-Acetylaspartate and Mitochondrial Dysfunction following Experimental Diffuse Traumatic Brain Injury
2004
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
2019
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases
2020 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Breast Cancer Statistics, 2022
2022 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data
2018 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
2009
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
2021
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
2007
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
2014
Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
2018 Standout
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma
2018
Implications of ATP-binding cassette transporters for brain pharmacotherapies
2007
Bromodomain and Extra-Terminal Motif Inhibitors: a Review of Preclinical and Clinical Advances in Cancer Therapy
2019
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Katherine E. Warren being referenced
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
2018
Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors
2001
Morphologic Characteristics and Immunohistochemical Profile of Diffuse Intrinsic Pontine Gliomas
2013
A Phase I study of concurrent RMP‐7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas
2005
Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors
2009
Measles, social media and surveillance in Baltimore City
2016
Diffuse intrinsic pontine glioma: poised for progress
2012
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group
2006
Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
2018
Current approaches to CNS tumors in infants and very young children
2004
Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition
2015
Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using 18F-FDG-PET and MRSI
2012
Genomic aberrations in pediatric diffuse intrinsic pontine gliomas
2011
Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates
2000
Phase I Study of O6-Benzylguanine and Temozolomide Administered Daily for 5 Days to Pediatric Patients With Solid Tumors
2005
Effect of Fluconazole on the Pharmacokinetics of Doxorubicin in Nonhuman Primates
2000
Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2'-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: implications for phase I study design.
2000
Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998–2013
2018
Real-time image-guided direct convective perfusion of intrinsic brainstem lesions
2007
Proton Magnetic Resonance Spectroscopic Imaging in Children With Recurrent Primary Brain Tumors
2000